LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
BT-20 Y39983
10
uM
LJP6
 2
P01
 72
hr
 1097 1515 3713 0.4080 0.2013
BT-20 Y39983
10
uM
LJP6
 3
P01
 72
hr
 1097 1594 3696 0.4312 0.2375
BT-20 Nintedanib
0.04
uM
LJP6
 1
H06
 72
hr
 1097 3683 3610 1.0201 1.0233
BT-20 Nintedanib
0.04
uM
LJP6
 2
H06
 72
hr
 1097 3458 3713 0.9311 0.9205
BT-20 Nintedanib
0.04
uM
LJP6
 3
H06
 72
hr
 1097 3539 3696 0.9574 0.9509
BT-20 Nintedanib
0.12
uM
LJP6
 1
H05
 72
hr
 1097 3145 3610 0.8711 0.8456
BT-20 Nintedanib
0.12
uM
LJP6
 2
H05
 72
hr
 1097 3513 3713 0.9460 0.9378
BT-20 Nintedanib
0.12
uM
LJP6
 3
H05
 72
hr
 1097 3511 3696 0.9498 0.9421
BT-20 Nintedanib
0.37
uM
LJP6
 1
H04
 72
hr
 1097 2763 3610 0.7653 0.7116
BT-20 Nintedanib
0.37
uM
LJP6
 2
H04
 72
hr
 1097 2789 3713 0.7510 0.6995
BT-20 Nintedanib
0.37
uM
LJP6
 3
H04
 72
hr
 1097 2915 3696 0.7886 0.7465
BT-20 Nintedanib
1.11
uM
LJP6
 1
H03
 72
hr
 1097 2844 3610 0.7877 0.7407
BT-20 Nintedanib
1.11
uM
LJP6
 2
H03
 72
hr
 1097 2806 3713 0.7556 0.7054
BT-20 Nintedanib
1.11
uM
LJP6
 3
H03
 72
hr
 1097 3017 3696 0.8162 0.7811
BT-20 Nintedanib
3.33
uM
LJP6
 1
H02
 72
hr
 1097 2686 3610 0.7439 0.6837
BT-20 Nintedanib
3.33
uM
LJP6
 2
H02
 72
hr
 1097 2750 3713 0.7405 0.6860
BT-20 Nintedanib
3.33
uM
LJP6
 3
H02
 72
hr
 1097 2440 3696 0.6601 0.5779
BT-20 Nintedanib
10
uM
LJP6
 1
H01
 72
hr
 1097 1998 3610 0.5534 0.4174
BT-20 Nintedanib
10
uM
LJP6
 2
H01
 72
hr
 1097 2053 3713 0.5528 0.4279
BT-20 Nintedanib
10
uM
LJP6
 3
H01
 72
hr
 1097 1794 3696 0.4853 0.3239
BT-20 Foretinib
0.04
uM
LJP5
 1
H12
 72
hr
 1097 3945 3735 1.0562 1.0628
BT-20 Foretinib
0.04
uM
LJP5
 2
H12
 72
hr
 1097 3950 3877 1.0186 1.0204
BT-20 Foretinib
0.04
uM
LJP5
 3
H12
 72
hr
 1097 4326 3925 1.1020 1.1085
BT-20 Foretinib
0.12
uM
LJP5
 1
H11
 72
hr
 1097 3599 3735 0.9635 0.9584
BT-20 Foretinib
0.12
uM
LJP5
 2
H11
 72
hr
 1097 3617 3877 0.9328 0.9250